Publications

Consideration of spatial companion biomarkers for targeted therapeutics in cancer: depatuxizumab mafodotin in glioblastoma

Download PDF
Resource: Consideration of spatial companion biomarkers for targeted therapeutics in cancer: depatuxizumab mafodotin in glioblastoma

.

Related Articles

Integrated immune profiling of chordomas reveals spatially organized niches and functional heterogeneity

Link
Morpho-molecular features of Epithelial Mesenchymal Transition associate with clinical outcome in patients with rectal cancer

Link